Sunday 5 December 2021
Home      All news      Contact us      RSS      India
business-standard - 10 days ago

ITC gains on buzz of developing COVID-19 nasal spray

ITC rose 1.27% to Rs 230.80 after the media reported that the company is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials.


Latest News
Hashtags:   

gains

 | 

developing

 | 

COVID

 | 

nasal

 | 

spray

 | 

Sources